{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:08:31Z","timestamp":1761217711295},"reference-count":0,"publisher":"Portico","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2014.50.2.2104040","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T10:26:10Z","timestamp":1400149570000},"page":"113","source":"Crossref","is-referenced-by-count":8,"title":["Idelalisib for the treatment of indolent non-Hodgkin's lymphoma"],"prefix":"10.3730","volume":"50","author":[{"family":"Lopez, J.P.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Jimeno, A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2014]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:09:50Z","timestamp":1685452190000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dcx321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2014.50.2.2104040","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}